Insights Into the Mechanisms of Sclerostin Action in Regulating Bone Mass Accrual
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insights Into the Mechanisms of Sclerostin Action in Regulating Bone Mass Accrual
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 29, Issue 1, Pages 24-28
Publisher
Wiley
Online
2013-11-28
DOI
10.1002/jbmr.2154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paradoxical Sost gene expression response to mechanical unloading in metaphyseal bone
- (2013) Brandon R. Macias et al. BONE
- High-concentration of BMP2 reduces cell proliferation and increases apoptosis via DKK1 and SOST in human primary periosteal cells
- (2013) Harry K.W. Kim et al. BONE
- Estrogen Receptor α Mediates Proliferation of Osteoblastic Cells Stimulated by Estrogen and Mechanical Strain, but Their Acute Down-regulation of the Wnt AntagonistSostIs Mediated by Estrogen Receptor β
- (2013) Gabriel L. Galea et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ReversingLRP5-Dependent Osteoporosis andSOSTDeficiency-Induced Sclerosing Bone Disorders by Altering WNT Signaling Activity
- (2013) Ming-Kang Chang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2
- (2013) Masakazu Kogawa et al. JOURNAL OF BONE AND MINERAL RESEARCH
- An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: Applications in mice with bone property alteringLrp5mutations
- (2013) Ugur M Ayturk et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
- (2013) Ju-Young Kim et al. LIFE SCIENCES
- HIF-1α Inhibits Wnt Signaling Pathway by Activating Sost Expression in Osteoblasts
- (2013) Dafu Chen et al. PLoS One
- Lrp5 and Lrp6 Exert Overlapping Functions in Osteoblasts during Postnatal Bone Acquisition
- (2013) Ryan C. Riddle et al. PLoS One
- Sclerostin Inhibition Reverses Skeletal Fragility in an Lrp5-Deficient Mouse Model of OPPG Syndrome
- (2013) R. Kedlaya et al. Science Translational Medicine
- Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper
- (2012) J. Goldhahn et al. CALCIFIED TISSUE INTERNATIONAL
- Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
- (2012) Hua Zhu Ke et al. ENDOCRINE REVIEWS
- Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors
- (2012) Gill Holdsworth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LRP5 and LRP6 in development and disease
- (2012) Danese M. Joiner et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Role of BMPs in Bone Anabolism and their Potential Targets SOST and DKK1
- (2012) Nobuhiro Kamiya Current Molecular Pharmacology
- Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1
- (2011) Nobuhiro Kamiya et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The sclerostin-bone protein interactome
- (2011) Hemamalini Devarajan-Ketha et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading
- (2011) Xiaolin Tu et al. BONE
- Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo
- (2011) Kyu Sang Joeng et al. DEVELOPMENTAL BIOLOGY
- Anabolic and Catabolic Regimens of Human Parathyroid Hormone 1–34 Elicit Bone- and Envelope-Specific Attenuation of Skeletal Effects inSost-Deficient Mice
- (2011) Alexander G. Robling et al. ENDOCRINOLOGY
- Sirt1 Is a Regulator of Bone Mass and a Repressor ofSostEncoding for Sclerostin, a Bone Formation Inhibitor
- (2011) Einav Cohen-Kfir et al. ENDOCRINOLOGY
- Sostdown-regulation by mechanical strain in human osteoblastic cells involves PGE2 signaling via EP4
- (2011) Gabriel L. Galea et al. FEBS LETTERS
- Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia
- (2011) Su Jin Kim et al. HUMAN GENETICS
- Bone Overgrowth-associated Mutations in theLRP4Gene Impair Sclerostin Facilitator Function
- (2011) Olivier Leupin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal structures of the extracellular domain of LRP6 and its complex with DKK1
- (2011) Zhihong Cheng et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6
- (2011) Eric Bourhis et al. STRUCTURE
- Sclerosteosis - An autosomal recessive disorder
- (2010) Peter Beighton et al. CLINICAL GENETICS
- Reconstitution of a Frizzled8·Wnt3a·LRP6 Signaling Complex Reveals Multiple Wnt and Dkk1 Binding Sites on LRP6
- (2010) Eric Bourhis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Wnt Isoform-Specific Interactions with Coreceptor Specify Inhibition or Potentiation of Signaling by LRP6 Antibodies
- (2010) Yan Gong et al. PLoS One
- Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies
- (2010) S. A. Ettenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Does osteocytic SOST suppression mediate PTH bone anabolism?
- (2010) Ina Kramer et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints
- (2009) S. Uderhardt et al. ANNALS OF THE RHEUMATIC DISEASES
- The Matricellular Protein Periostin Is Required forSostInhibition and the Anabolic Response to Mechanical Loading and Physical Activity
- (2009) Nicolas Bonnet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
- (2009) Ina Kramer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A cell-based Dkk1 binding assay reveals roles for extracellular domains of LRP5 in Dkk1 interaction and highlights differences between wild-type and the high bone mass mutant LRP5(G171V)
- (2009) Richard J. Murrills et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
- (2009) Hong Y. Choi et al. PLoS One
- The Binding Between Sclerostin and LRP5 is Altered by DKK1 and by High-Bone Mass LRP5 Mutations
- (2008) Wendy Balemans et al. CALCIFIED TISSUE INTERNATIONAL
- Lrp6 Hypomorphic Mutation Affects Bone Mass Through Bone Resorption in Mice and Impairs Interaction With Mesd
- (2008) Takuo Kubota et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now